Lv4
440 积分 2020-08-12 加入
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)
11小时前
已完结
Deciphering the Complex Immunopathogenesis of Alopecia Areata
12小时前
已完结
Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population
12小时前
已完结
Alopecia Areata: Current Treatments and New Directions
12小时前
已完结
Dual Antagonism of α9α10 nAChR and GABAB Receptor-Coupled CaV2.2 Channels by an Analgesic αO-Conotoxin Analogue
14天前
已完结
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial
27天前
已完结
Upadacitinib for Refractory Alopecia Areata Unresponsive to Prior Systemic Therapies: A Retrospective Study
27天前
已完结
Recent Progress in JAK Inhibitors for the Treatment of Rheumatoid Arthritis
27天前
已完结
THU0127 Pharmacodynamics of A Novel JAK1 Selective Inhibitor in Rat Arthritis and Anemia Models and in Healthy Human Subjects
27天前
已完结
Janus Kinase Inhibitors for Alopecia Areata: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
27天前
已完结
皖公网安备34019202002308
